Kiran Mazumdar-Shaw
Chairperson, Biocon Group
Topics
News
- India’s Tech Workforce Gives It Edge in AI Race, Cognizant's Hodjat Says
- Emergence Picks Bengaluru for AI Lab, Plans 500 Hires
- Nazara to Buy Control of Bluetile, BestPlay in $100 Million Gaming Bet
- TCS, Pearson Move to Close Gap Between AI Spend and Results
- HDFC Bank's Chakraborty Resigns Citing Internal Practices, Shares Fall
- Snowflake Pushes AI From Insight to Execution With SnowWork
Kiran Mazumdar-Shaw is the Founder and Chairperson of Biocon Group, one of India’s leading biopharmaceutical companies. She established Biocon in 1978 as an industrial enzymes company and led its evolution into a fully integrated biopharmaceutical enterprise focused on biosimilars, generics and novel biologics.
Under her leadership, Biocon expanded internationally and positioned itself as a significant player in affordable insulin, oncology and immunology therapies. Mazumdar-Shaw has been an advocate for innovation-led growth in biotechnology and greater investment in research and development within India’s life sciences sector.
She holds a bachelor’s degree in zoology from Bangalore University and a postgraduate qualification in malting and brewing from Australia. She has been awarded the Padma Shri and the Padma Bhushan for her contributions to industry and has served on multiple global advisory and academic boards.
